Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Brain, Behavior, and Immunity|December 3, 2014
Comparison of Pandemrix and Arepanrix, two pH1N1 AS03-adjuvanted vaccines differentially associated with narcolepsy developmentLouis Jacob, Ryan Leib, Hanna M Ollila, et al.
Molecular Immunology|February 2, 2011
Inorganic arsenic alters expression of immune and stress response genes in activated primary human T lymphocytesCorinne Martin-Chouly, Claudie Morzadec, Mélodie Bonvalet, et al.
European Journal of Cancer (Oxford, England : 1990)|January 19, 2023
Rationale for LDH-targeted cancer immunotherapyTina B S Miholjcic, Heloise Halse, Mélodie Bonvalet, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2018
Autoimmunity to hypocretin and molecular mimicry to flu in type 1 narcolepsyGuo Luo, Aditya Ambati, Ling Lin, et al.
Plos One|December 9, 2017
Absence of anti-hypocretin receptor 2 autoantibodies in post pandemrix narcolepsy casesGuo Luo, Ling Lin, Louis Jacob, et al.
Plos One|March 29, 2019
Correction: Absence of anti-hypocretin receptor 2 autoantibodies in post pandemrix narcolepsy casesGuo Luo, Ling Lin, Louis Jacob, et al.
Oncoimmunology|September 16, 2020
Trial watch : the gut microbiota as a tool to boost the clinical efficacy of anticancer immunotherapyRomain Daillère, Lisa Derosa, Mélodie Bonvalet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 15, 2026
HPV16 genomic status stratifies risk of disease recurrence in oropharyngeal squamous cell carcinomaVictor Malassigné, Julien Puech, Sandrine Imbeaud, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 7, 2023
Immune checkpoints are predominantly co-expressed by clonally expanded CD4<sup>+</sup>FoxP3<sup>+</sup> intratumoral T-cells in primary human cancersDelphine Bredel, Edi Tihic, Séverine Mouraud, et al.
European Urology|May 8, 2020
Gut Bacteria Composition Drives Primary Resistance to Cancer Immunotherapy in Renal Cell Carcinoma PatientsLisa Derosa, Bertrand Routy, Marine Fidelle, et al.
Pageof 2